Compare Baxter International Inc (BAX) vs ArcelorMittal SA (MT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Baxter International Inc vs ArcelorMittal SA — how do they compare? Baxter International Inc trades at $27.56 (market cap $14.27B), while ArcelorMittal SA trades at $74.92 (market cap $55.88B). The key difference: ArcelorMittal SA is far larger — about 3.9× Baxter International Inc's market cap, and ArcelorMittal SA pays the higher dividend (0.81%). Which is the better fit depends on your goals.
| BAX | MT | |
|---|---|---|
Market Cap | $14.27B | $55.88B |
Sector | Health | Basic Materials |
52-Week High | $28.35 | $75.35 |
52-Week Low | $15.80 | $32.44 |
Enterprise Value | $21.79B | $65.45B |
Dividend Yield | 0.14% | 0.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Baxter International Inc. (BAX) trades at $27.78, up 0.83% today, with a bullish technical outlook supported by moving averages. Recent Q2 2026 earnings beat estimates with EPS of $0.56 versus $0.37 expected, and revenue guidance was raised, signaling operational improvement. However, the company posted a net loss of -$957 million in 2025, with negative profit margins and high P/E of 87.85, reflecting valuation concerns amid turnaround efforts.
The stock shows potential from earnings momentum and cost initiatives, but high debt and inconsistent profitability pose risks. Analyst consensus is mixed with a $25.43 price target below current levels, suggesting cautious optimism. Investors should weigh recent beats against structural challenges in the medtech sector.
ArcelorMittal (MT) trades at $73.90, up 0.83% with bullish technical signals and strong institutional support. The stock shows improving fundamentals with Q2 2026 revenue growth despite an earnings miss, while maintaining stable dividends. Recent news highlights strategic partnerships and European business recovery prospects.
Outlook remains cautiously optimistic with 50% analyst buy ratings, though risks include cyclical steel demand and margin pressures. The current P/E of 30.97 appears elevated relative to historical norms, requiring sustained earnings growth to justify valuation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Baxter International Inc
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →About ArcelorMittal SA
ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →
